Hikma Pharmaceuticals (HIK) Ordinary GBP 0.10
13.50p
(0.86%)
- Add to watchlist
- Create an alert
- This stock can be held in a
13.50p
(0.86%)
13.50p
(0.86%)
1,549.00p
1,563.50p
2,089.00p
£3.74 bn
1,563.50p
1,541.00p
814.20p
19.19
6.00p (0.39%) Previous:
6.00p
532,757
1.58%
1,000
Performance
| 1 week 1W | 0.51% | 1 year 1Y | 55.19% |
|---|---|---|---|
| 1 month 1M | 16.95% | 2 years 2Y | 17.67% |
| 3 months 3M | 12.34% | 3 years 3Y | 25.69% |
| 6 months 6M | 1% | 5 years 5Y | 25.08% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/12/2017 | 31/12/2016 |
|---|---|---|
| Revenue ($m) | 1,936.00 | 1,950.00 |
| Profit before tax ($m) | (738.00) | 210.00 |
| Adjusted EPS (¢): | 105.00 | 118.50 |
| P/E ratio | 13.90 | 20.60 |
| PEG | n/a | n/a |
| EPS growth (%) | (11.00) | (18.00) |
Values are quoted in the stock's local currency: US dollar
All fundamental dataRecent dividends paid or declared by Hikma Pharmaceuticals:
| Type | Ex-div date | Payment date | Amount |
|---|---|---|---|
| Interim | 23/08/2018 | 21/09/2018 | 12.00¢ |
| Final | 05/04/2018 | 24/05/2018 | 23.00¢ |
| Interim | 24/08/2017 | 22/09/2017 | 11.00¢ |
| Final | 06/04/2017 | 25/05/2017 | 22.00¢ |
| Interim | 01/09/2016 | 30/09/2016 | 11.00¢ |
This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.
Full dividend historyFive years' total annual Hikma Pharmaceuticals dividends:
| Financial year end |
Dividend yield |
Dividend cover |
Total dividend paid |
|---|---|---|---|
| 31/12/2017 | 2.30% | 3.09 | $0.34 |
| 31/12/2016 | 1.40% | 3.59 | $0.33 |
| 31/12/2015 | 1.10% | 4.49 | $0.32 |
| 31/12/2014 | 0.90% | 6.86 | $0.32 |
| 31/12/2013 | 1.30% | 6.96 | $0.27 |
All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.
Full dividend historyOpen an easy to manage, low cost dealing account in less than 5 minutes
Deal shares from just £11.95 per trade online, and as low as £5.95 per trade for active traders.
More about the Fund and Share AccountImportant Documents
There are no documents available for this stock.
Broker forecasts
-
Strong Sell
(0 of 5) -
Sell
(0 of 5) -
Neutral
(3 of 5) -
Buy
(0 of 5) -
Strong Buy
(2 of 5)
This is not a recommendation, it represents the consensus view of a basket of brokers. If fewer than 5 brokers it may not be a valid consensus. HL might not concur and takes no responsibility.
Full broker forecasts-
Hikma 'thrilled' by US injectables contract win
3 January 2019 11:19
-
Hikma US launches generic version of Lundbeck's Onfi
10 December 2018 14:18
-
New management to reinvigorate Smith & Nephew, says Morgan Stanley
10 December 2018 13:31
-
Hikma announces agreement with Sciecure Pharma
3 January 2019 09:00
-
Shire
19 December 2018 18:30
-
Hikma launches Clobazam
10 December 2018 09:00
| Time / date Time | Buy / sell Type | Volume | Price | Value |
|---|
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.